Therapeutic effects of cytokine gene therapy and suicide gene therapy for gastrointestinal tumors
细胞因子基因治疗和自杀基因治疗对胃肠道肿瘤的治疗效果
基本信息
- 批准号:11670556
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(1)We explored possibility of gene therapy for gastrointestinal tumors using cytokine genes that direct Th-1 type T cells. Three cytokine genes, IL-12, IL-15 and IL-18 gene, were cloned with a RT-PCR method. These cytokines induces the differentiation of immature T cells into Th-1 type cells or are secreted from Th-1 type cells. Human pancreatic and murine colon carcinoma cells were retrovirally transduced with the cytokine genes and were inoculated into immunocompetent or immunocompromized mice. Syngeneic mice rejected the cytokine producers and the mice developed tumor-specific, T cell-dependent protective immunity. Anti-tumor effects were also produced in immunocompromized hosts and a number of mechanisms such as anti-angiogenesis were involved in the anti-tumor activity. (2)We took another approarch to express a suicide gene specifically in tumor cells. The promoter region of the midkine gene, whose expression was predominantly observed in a number of gastrointestinal tissues but not in normal tissues, should enable the tumor-specific gene expression. In fact we detected the midkine gene expression in 14 out 15 hepatocellular specimens and identified a 0.5-kb promoter region within the regulatory sequences, which was responsible for preferential expression of a fused foreign gene in tumor cells. Human pancreatic carcinoma cells transduced with the promoter-linked herpes simplex virus-thymidine kinase gene became sensitive to ganciclovir compared with untransduced parent cells.
(1)我们使用指向T型T细胞的细胞因子基因探索了基因治疗对胃肠道肿瘤的可能性。用RT-PCR方法克隆了三个细胞因子基因IL-12,IL-15和IL-18基因。这些细胞因子诱导未成熟的T细胞分化为Th-1型细胞,或者从TH-1型细胞中分泌。用细胞因子基因逆转录病毒转导的人胰腺和鼠结肠癌细胞,并接种到免疫功能或免疫功能低下的小鼠中。合成小鼠拒绝细胞因子生产者,而小鼠产生了肿瘤特异性,T细胞依赖性保护性免疫。在免疫功能低下的宿主中还产生了抗肿瘤作用,抗肿瘤活性涉及许多机制,例如抗血管生成。 (2)我们采取了另一种批准来表达在肿瘤细胞中特别表达自杀基因。 Midkine基因的启动子区域,其表达主要在许多胃肠道组织中观察到,但在正常组织中不应启用肿瘤特异性基因表达。实际上,我们检测到14个肝细胞标本中的14个中胺基因表达,并在调节序列中鉴定出一个0.5 kb的启动子区域,该序列负责在肿瘤细胞中优先表达融合的外源基因。与未转移的亲本细胞相比,用启动子连接的单纯胸腺胰岛素激酶基因转导的人胰腺癌细胞对Ganciclovir敏感。
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kimura M.,Saisho H.et al.: "Acquired immunity in nude mice induced by the expression of IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transter using retrovirus"Int.J.Cancer. 82. 549-555 (1999)
Kimura M.,Saisho H.等人:“人胰腺癌细胞中表达IL-2或IL-4基因诱导的裸鼠获得性免疫以及使用逆转录病毒进行体内基因转移产生的抗肿瘤作用”Int
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshida H.,Kawamura K.et al.: "Induced immunity by the expression of interleukin-2 or granulocyte macrophagecolony stimulating factor gene in murine neuroblastoma cells generated antitumor response for established tumors"Cancer Gene Ther.. 6. 395-401 (199
Yoshida H.、Kawamura K.等人:“通过在小鼠神经母细胞瘤细胞中表达白细胞介素 2 或粒细胞巨噬细胞集落刺激因子基因诱导免疫,对已建立的肿瘤产生抗肿瘤反应”Cancer Gene Ther.. 6. 395-401 (199
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Miyauchi, M., Shimada, H., Kadomatsu, K., Muramatsu, T., Matsubara, S., Ikematsu, S., Takenaga, K., Asano, T., Ochiai, T., Sakiyama, S.and Tagawa, M.: "Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for
宫内 M.、岛田 H.、门松 K.、村松 T.、松原 S.、池松 S.、竹永 K.、浅野 T.、落合 T.、崎山 S. 和
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tasaki K.,Tagawa M.et al.: "Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effect in immunocompetent and immunocompromised hosts"Cancer Gene Ther.. (in press).
Tasaki K.、Takawa M.等人:“用白介素-15 基因转导小鼠结肠癌细胞可在免疫功能正常和免疫功能低下的宿主中诱导抗肿瘤作用”Cancer Gene Ther..(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kawamura, K. , Tagawa, M. et al.: "Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts."Cancer Lett. 156. 151-157 (2000)
Kawamura, K.、Takawa, M. 等人:“在啮齿动物肿瘤细胞中转导人脱氧胞苷激酶基因会在同基因宿主中诱导体内生长迟缓。”Cancer Lett。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAWAMURA Kiyoko其他文献
KAWAMURA Kiyoko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAWAMURA Kiyoko', 18)}}的其他基金
Anti-tumor effects for solid tumors in digestive tracts were produced by a chimeric type of oncolytic adenoviruses and the carrier cells
嵌合型溶瘤腺病毒和载体细胞对消化道实体瘤产生抗肿瘤作用
- 批准号:
21590879 - 财政年份:2009
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Therapeutic strategies with chimeric oncolytic adenoviruses and a cell-mediated delivery system for gastrointestinal solid tumors
嵌合溶瘤腺病毒和细胞介导的递送系统治疗胃肠道实体瘤的治疗策略
- 批准号:
19590798 - 财政年份:2007
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene therapy for gastrointestinal tumors with adenovirus in which the fiber-knob region was replaced
用腺病毒治疗胃肠道肿瘤,其中纤维旋钮区域被替换
- 批准号:
17590692 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene therapy for intractable gastrointestinal tumors with tumor promoter-mediated oncolyitc adenoviruses
肿瘤启动子介导的溶瘤腺病毒对难治性胃肠道肿瘤的基因治疗
- 批准号:
15590706 - 财政年份:2003
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suicide gene therapy for intractable gastrointestinal cancer with tumor specific promoters
具有肿瘤特异性启动子的自杀基因治疗顽固性胃肠癌
- 批准号:
13670580 - 财政年份:2001
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
- 批准号:32370967
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
- 批准号:82300966
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
蛋白降解识别器ZER1调控细胞因子IL32抑制炎症性肠病发生发展及其机制研究
- 批准号:82300611
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新细胞因子LYG1增强Th1细胞功能在干眼中发挥促炎作用的机制研究
- 批准号:82301177
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型肝素结合细胞因子Midkine调控PAI-1/PI3K通路在脑胶质瘤血管拟态中的分子机制研究
- 批准号:82303509
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidation of pathophysiology of ischemia reperfusion injury jn isolated perfused rat lungs
离体灌注大鼠肺缺血再灌注损伤病理生理学的阐明
- 批准号:
11470317 - 财政年份:1999
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)